Current Research in Pharmacology and Drug Discovery

Current Research in Pharmacology and Drug Discovery (CRPHAR) is a new primary research, gold open access journal from Elsevier. CRPHAR publishes original papers, reviews, graphical reviews, short communications and follow-up manuscripts resulting from research in pharmacology and drug discovery that cover aspects of drug action at the cellular, molecular, and biochemical level.

Current Research in Pharmacology and Drug Discovery is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is a companion to the highly regarded review journal Current Opinion in Pharmacology (2020 Journal Impact Factor 5.547, CiteScore 9.3) and is part of the Current Opinion and Research (CO+RE) suite of journals . All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.

Current Research in Pharmacology and Drug Discovery topics covered include neuropharmacology (psychiatry and neurodegeneration); sensory pharmacology (ocular, auditory and pain); cardiovascular; renal; respiratory; musculoskeletal; cancer; immunopharmacology (inflammation and innate immune system function); anti-infectives; gastrointestinal; endocrine; metabolic; systems pharmacology and signalling; drug metabolism; pharmaceutics and drug delivery; pharmacogenetics; analytical toxicology; pharmacokinetics; new technologies; and translational and clinical pharmacology.

Current Research in Pharmacology and Drug Discovery builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health.

• Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal.

• Speed - Submission and peer review is fast, and publication of final manuscripts is instantaneous.

• Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience.

Ethics in Publishing: General Statement

The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing.
For more information, please refer to: https://www.elsevier.com/conflictsofinterest